Fred T. Fiedorek

2.9k total citations · 1 hit paper
36 papers, 2.1k citations indexed

About

Fred T. Fiedorek is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Fred T. Fiedorek has authored 36 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Physiology. Recurrent topics in Fred T. Fiedorek's work include Diabetes Treatment and Management (13 papers), Metabolism, Diabetes, and Cancer (8 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Fred T. Fiedorek is often cited by papers focused on Diabetes Treatment and Management (13 papers), Metabolism, Diabetes, and Cancer (8 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Fred T. Fiedorek collaborates with scholars based in United States, United Kingdom and Canada. Fred T. Fiedorek's co-authors include James F. List, Enrique Morales, Vincent Woo, Weihua Tang, Paul Norwood, Caroline T'joen, Arnaud Bastien, John Wilding, Mustafa A. Noor and Donald E. Kohan and has published in prestigious journals such as Circulation, Nature Medicine and Gastroenterology.

In The Last Decade

Fred T. Fiedorek

36 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes

2008 569 citations James F. List, Vincent Woo et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fred T. Fiedorek United States	15	1.3k	870	619	259	237	36	2.1k
Barry Gumbiner United States	25	1.1k 0.9×	597 0.7×	1.3k 2.1×	177 0.7×	635 2.7×	51	2.7k
Ilaria Ferrari Italy	30	932 0.7×	752 0.9×	298 0.5×	273 1.1×	288 1.2×	79	2.1k
David P. Sonne Denmark	21	783 0.6×	502 0.6×	604 1.0×	141 0.5×	277 1.2×	53	1.6k
Diane K. Jorkasky United States	27	350 0.3×	341 0.4×	353 0.6×	144 0.6×	138 0.6×	68	1.7k
Kathleen Wyne United States	21	994 0.8×	565 0.6×	986 1.6×	151 0.6×	364 1.5×	64	2.5k
Prajakti A. Kothare United States	22	1.1k 0.9×	480 0.6×	601 1.0×	330 1.3×	138 0.6×	35	1.8k
Valdis Pīrāgs Latvia	22	1.0k 0.8×	877 1.0×	527 0.9×	94 0.4×	269 1.1×	86	2.1k
Michael P. O’Donnell United States	25	521 0.4×	474 0.5×	692 1.1×	149 0.6×	372 1.6×	51	2.7k
Curtis Triplitt United States	30	1.8k 1.4×	1.1k 1.3×	834 1.3×	246 0.9×	527 2.2×	89	2.7k
David S.H. Bell United States	16	1.3k 1.0×	877 1.0×	739 1.2×	180 0.7×	355 1.5×	36	2.7k

Countries citing papers authored by Fred T. Fiedorek

Since Specialization

Citations

This map shows the geographic impact of Fred T. Fiedorek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred T. Fiedorek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred T. Fiedorek more than expected).

Fields of papers citing papers by Fred T. Fiedorek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred T. Fiedorek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred T. Fiedorek. The network helps show where Fred T. Fiedorek may publish in the future.

Co-authorship network of co-authors of Fred T. Fiedorek

This figure shows the co-authorship network connecting the top 25 collaborators of Fred T. Fiedorek. A scholar is included among the top collaborators of Fred T. Fiedorek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred T. Fiedorek. Fred T. Fiedorek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruff, Christian T., Michelle A. Baron, KyungAh Im, et al.. (2021). Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trial. Nature Medicine. 28(1). 89–95. 69 indexed citations

Fehnel, Sheri, Fred T. Fiedorek, Lauren Nelson, et al.. (2019). <p>Development and psychometric evaluation of the Diabetic Gastroparesis Symptom Severity Diary</p>. Clinical and Experimental Gastroenterology. Volume 12. 93–103. 6 indexed citations

Fazeli, Pouneh K., Elizabeth A. Lawson, Alexander T. Faje, et al.. (2017). Treatment With a Ghrelin Agonist in Outpatient Women With Anorexia Nervosa. The Journal of Clinical Psychiatry. 79(1). 17m11585–17m11585. 51 indexed citations

Camilleri, Michael, Richard W. McCallum, Jan Tack, et al.. (2017). Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study. Gastroenterology. 153(5). 1240–1250.e2. 111 indexed citations

Hess, Connie N., Matthew T. Roe, C. Michael Gibson, et al.. (2014). Independent data monitoring committees: Preparing a path for the future. American Heart Journal. 168(2). 135–141.e1. 13 indexed citations

Frederich, Robert, John H. Alexander, Fred T. Fiedorek, et al.. (2010). A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes. Postgraduate Medicine. 122(3). 16–27. 182 indexed citations

Henry, Robert R., Steven C. Smith, James F. List, et al.. (2009). β-cell stimulation by saxagliptin in patients with type 2 diabetes. ResearchOnline at James Cook University (James Cook University). 6 indexed citations

List, James F., Vincent Woo, Enrique Morales, Weihua Tang, & Fred T. Fiedorek. (2008). Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes. Diabetes Care. 32(4). 650–657. 569 indexed citations breakdown →

Rubin, Cindy J., Jean-Marie Ledeine, & Fred T. Fiedorek. (2008). Improvement of glycaemic and lipid profiles with muraglitazar plus metformin in patients with type 2 diabetes: an active-control trial with glimepiride. Diabetes and Vascular Disease Research. 5(3). 168–176. 13 indexed citations

10.

Bruce, R. Douglas, et al.. (2006). Beta-cell response to metformin-glibenclamide combination tablets (Glucovance®) in patients with type 2 diabetes. International Journal of Clinical Practice. 60(7). 783–790. 11 indexed citations

11.

Dailey, George, Mustafa A. Noor, Jong-Soon Park, Simon Bruce, & Fred T. Fiedorek. (2004). Glycemic control with Glyburide/Metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial. The American Journal of Medicine. 116(4). 223–229. 77 indexed citations

12.

Noor, Mustafa A., Rex A. Parker, Edward O’Mara, et al.. (2004). The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults. AIDS. 18(16). 2137–2144. 155 indexed citations

13.

Garber, Alan J., Simon Bruce, & Fred T. Fiedorek. (2002). Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: an open-label extension study. Clinical Therapeutics. 24(9). 1401–1413. 13 indexed citations

14.

Fiedorek, Fred T., et al.. (2000). Monotherapy with GI262570, a non-thiazolidinedione PPARγ agonist, reduces triglyceride and increases HDL-C in patients with type 2 diabetes. Diabetes Research and Clinical Practice. 50. 40–40. 1 indexed citations

15.

Qu, Wei, Richard A. Rippe, Jixiang Ma, et al.. (1998). Nutritional Status Modulates Rat Liver Cytochrome P450 Arachidonic Acid Metabolism. Molecular Pharmacology. 54(3). 504–513. 31 indexed citations

16.

Mock, Beverly A., Paul E. Neumann, & Fred T. Fiedorek. (1997). Mouse chromosome 4. Mammalian Genome. 7(S1). S60–S79. 2 indexed citations

17.

McAllister, Kimberly A., Sridhar Ramachandran, Astrid C. Haugen, Fred T. Fiedorek, & Roger W. Wiseman. (1997). Genetic mapping of the Brca2 breast cancer susceptibility gene on mouse Chromosome 5. Mammalian Genome. 8(7). 540–541. 3 indexed citations

18.

Mock, Beverly A., Jonathan P. Stoye, John R. Spence, et al.. (1996). Encyclopedia of the mouse genome V. Mouse chromosome 4.. PubMed. 6 Spec No. S73–96. 7 indexed citations

19.

Abbott, Catherine M., Robert D. Blank, Janan T. Eppig, et al.. (1993). Mouse chromosome 4. Mammalian Genome. 4(S1). S58–S71. 11 indexed citations

20.

Kohan, Donald E. & Fred T. Fiedorek. (1991). Endothelin synthesis by rat inner medullary collecting duct cells.. Journal of the American Society of Nephrology. 2(2). 150–155. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact